Skip to content
United States/Newsroom/Infectious diseases & vaccines/Janssen and Global Partners to Discontinue Phase 3 Mosaico HIV Vaccine Clinical Trial
Janssen and Global Partners to Discontinue Phase 3 Mosaico HIV Vaccine Clinical Trial
January 18, 2023
1 min read
